Anxiety Due to COVID-19 and Treatment Access High in Iran, Survey Finds

Anxiety Due to COVID-19 and Treatment Access High in Iran, Survey Finds
A survey of people with Parkinson’s disease in Iran found significantly higher levels of anxiety due to the COVID-19 pandemic among them compared with the general population, a study reported.  Patients’ anxiety was primarily driven by fears of contracting the virus as well as not having access to medication.  The study, “Incidence of Anxiety in Parkinson’s Disease during Coronavirus disease ... read more
Source: Parkinson’s News TodayPublished on 2020-05-14By Steve Bryson PhD